Royal Victoria Infirmary

Hospital


Location: Newcastle upon Tyne, United Kingdom (GB) GB

ISNI: 0000000406413236

ROR: https://ror.org/01p19k166

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Erratum to: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma (Nature Communications, (2018), 9, 1, (3707), 10.1038/s41467-018-04989-w) (2019) Went M, Sud A, Foersti A, Halvarsson BM, Weinhold N, Kimber S, Van Duin M, et al. Journal article, Erratum Global Consensus on Definition, Classification, Diagnosis, and Staging of Limbal Stem Cell Deficiency (2019) Deng SX, Borderie V, Chan CC, Dana R, Figueiredo FC, Gomes JAP, Pellegrini G, et al. Journal article Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology (2019) Went M, Sud A, Speedy H, Sunter NJ, Foersti A, Law PJ, Johnson DC, et al. Journal article Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course (2019) Wefers AK, Stichel D, Schrimpf D, Coras R, Pages M, Tauziède-Espariat A, Varlet P, et al. Journal article Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma (2018) Went M, Sud A, Forsti A, Halvarsson BM, Weinhold N, Kimber S, Van Duin M, et al. Journal article Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial (2018) Pavel ME, Gross DJ, Benavent M, Perros P, Srirajaskanthan R, Warner RRP, Kulke MH, et al. Journal article Telotristat Ethyl in Carcinoid Syndrome: Safety and Efficacy Results of an Open-Label Extension of the TELECAST Phase 3 Clinical Trial (2018) Pavel M, Benavent M, Perros P, Srirajaskanthan R, Warner RRP, Kulke MH, Anthony LB, et al. Conference contribution Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target (2018) Apps JR, Carreno G, Mario Gonzalez-Meljem J, Haston S, Guiho R, Cooper JE, Manshaei S, et al. Journal article Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach (2017) Went M, Sud A, Law PJ, Johnson DC, Weinhold N, Forsti A, Van Duin M, et al. Journal article Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in Europe (2015) Boelling T, Braun-Munzinger G, Burdach S, Calaminus G, Craft A, Delattre O, Deley MCL, et al. Journal article